Olek MJ - Search Results

1

Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study.

Sperling RA, Guttmann CR, Hohol MJ, Warfield SK, Jakab M, Parente M, Diamond EL, Daffner KR, Olek MJ, Orav EJ, Kikinis R, Jolesz FA, Weiner HL. Sperling RA, et al. Among authors: olek mj. Arch Neurol. 2001 Jan;58(1):115-21. doi: 10.1001/archneur.58.1.115. Arch Neurol. 2001. PMID: 11176944

2

Oral contraceptives and the incidence of multiple sclerosis.

Hernán MA, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A. Hernán MA, et al. Among authors: olek mj. Neurology. 2000 Sep 26;55(6):848-54. doi: 10.1212/wnl.55.6.848. Neurology. 2000. PMID: 10994007

3

Methotrexate in the treatment of multiple sclerosis.

Olek MJ, Hohol MJ, Weiner HL. Olek MJ, et al. Ann Neurol. 1996 May;39(5):684. doi: 10.1002/ana.410390525. Ann Neurol. 1996. PMID: 8619559 Clinical Trial. No abstract available.

4

Seasonal variation of interferon-gamma production in progressive multiple sclerosis.

Balashov KE, Olek MJ, Smith DR, Khoury SJ, Weiner HL. Balashov KE, et al. Among authors: olek mj. Ann Neurol. 1998 Nov;44(5):824-8. doi: 10.1002/ana.410440519. Ann Neurol. 1998. PMID: 9818941

5

Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.

Hohol MJ, Olek MJ, Orav EJ, Stazzone L, Hafler DA, Khoury SJ, Dawson DM, Weiner HL. Hohol MJ, et al. Among authors: olek mj. Mult Scler. 1999 Dec;5(6):403-9. doi: 10.1177/135245859900500i606. Mult Scler. 1999. PMID: 10618696

6

Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.

Frohman EM, Havrdova E, Lublin F, Barkhof F, Achiron A, Sharief MK, Stuve O, Racke MK, Steinman L, Weiner H, Olek M, Zivadinov R, Corboy J, Raine C, Cutter G, Richert J, Filippi M. Frohman EM, et al. Arch Neurol. 2006 Apr;63(4):614-9. doi: 10.1001/archneur.63.4.614. Arch Neurol. 2006. PMID: 16606781 No abstract available.

7

A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.

Smith DR, Weinstock-Guttman B, Cohen JA, Wei X, Gutmann C, Bakshi R, Olek M, Stone L, Greenberg S, Stuart D, Orav J, Stuart W, Weiner H. Smith DR, et al. Mult Scler. 2005 Oct;11(5):573-82. doi: 10.1191/1352458505ms1210oa. Mult Scler. 2005. PMID: 16193896 Clinical Trial.

8

Recent use of oral contraceptives and the risk of multiple sclerosis.

Alonso A, Jick SS, Olek MJ, Ascherio A, Jick H, Hernán MA. Alonso A, et al. Among authors: olek mj. Arch Neurol. 2005 Sep;62(9):1362-5. doi: 10.1001/archneur.62.9.1362. Arch Neurol. 2005. PMID: 16157743

9

Vitamin D intake and incidence of multiple sclerosis.

Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A. Munger KL, et al. Among authors: olek mj. Neurology. 2004 Jan 13;62(1):60-5. doi: 10.1212/01.wnl.0000101723.79681.38. Neurology. 2004. PMID: 14718698

10

Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study.

Hernán MA, Jick SS, Olek MJ, Jick H. Hernán MA, et al. Among authors: olek mj. Neurology. 2004 Sep 14;63(5):838-42. doi: 10.1212/01.wnl.0000138433.61870.82. Neurology. 2004. PMID: 15365133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters